Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Polyps 2Hyperplasia 2Carcinoma 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 3Radiotherapy 2Radiation 2Platinum 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Disulfides 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2(225)Ac-DOTA-c(RGDyK) 2menatetrenone 1durvalumab 1atezolizumab 1Surgical Procedures, Operative 1Specimen Handling 1Photochemotherapy 1Neck Dissection 1Irinotecan 1Gemcitabine 1Endoscopy 1Docetaxel 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Carcinoma × Endoscopy × Clear all
NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting
498 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡